AVYCAZ | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

AVYCAZ
Canada

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

AVYCAZ

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 18 USDMF, 16 CEP/COS, 6 JDMF, 4 EU WC, 4 KDMF, 4 NDC API, 15 Listed Suppliers, $ API Reference Price

40 API Suppliers
18 USDMF
16 CEP/COS
6 JDMF
4 EU WC
4 KDMF
4 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

222 FDF Dossiers, 42 FDA Orange Book, 100 Europe, 6 Canada, 16 South Africa, 58 Listed Dossiers

222 FDF Dossiers
42 FDA Orange Book
100 Europe
6 Canada
16 South Africa
58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 20MG BASE/ML, INJECTABLE;INJECTION - EQ 40MG BASE/ML, INJECTABLE;INJECTION - EQ 1GM BASE, INJECTABLE;INJECTION - EQ 2GM BASE

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL
INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 20MG BASE/ML
INJECTABLE;INJECTION - EQ 40MG BASE/ML
INJECTABLE;INJECTION - EQ 1GM BASE
INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

1 Actylis
1 Kerry
1 Microlex e.U
1 Pluviaendo
1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Fillers, Diluents & Binders, 2 Parenteral, 1 Taste Masking, 1 Co-Processed Excipients

2 Fillers, Diluents & Binders
2 Parenteral
1 Taste Masking
1 Co-Processed Excipients

DIGITAL CONTENT

25 NEWS #PharmaBuzz

25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 82 Finished Drug Prices, 8 Annual Reports

3 US Medicaid Prescriptions
82 Finished Drug Prices
8 Annual Reports

MARKET PLACE

22 APIs, 20 FDF Dossiers

22 APIs
20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 4 US Exclusivities, 16 Health Canada Patents

10 US Patents
4 US Exclusivities
16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

2 EDQM
2 USP
4 Others

$ API Ref.Price (USD/KG) : 374 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 3FRESENIUS KABI CANADA LTD

02 3STERIMAX INC

filter Active Ingredients Reset all filters

6 All

01 3CEFTAZIDIME

02 3CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

filter Dosage Form Reset all filters

6 All

01 6POWDER FOR SOLUTION

filter Brand Name Reset all filters

6 All

01 3CEFTAZIDIME FOR INJECTION BP

02 3CEFTAZIDIME FOR INJECTION, USP

List of Suppliers

Product Main Page

01

FRESENIUS KABI CANADA LTD

Austria

PharmScience R&D

Not Confirmed

FRESENIUS KABI CANADA LTD

Austria

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Austria

Digital Content

Regulatory Info :

Registration Country : Canada

CEFTAZIDIME

Brand Name : CEFTAZIDIME FOR INJECTION, USP

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 6G/VIAL

Packaging : 30/60ML-(200-100MG/ML)

Approval Date :

Application Number : 886963

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

FRESENIUS KABI CANADA LTD

Austria

PharmScience R&D

Not Confirmed

FRESENIUS KABI CANADA LTD

Austria

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Austria

Digital Content

Regulatory Info :

Registration Country : Canada

CEFTAZIDIME

Brand Name : CEFTAZIDIME FOR INJECTION, USP

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 2G/VIAL

Packaging : 11.2ML

Approval Date :

Application Number : 886955

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

FRESENIUS KABI CANADA LTD

Austria

PharmScience R&D

Not Confirmed

FRESENIUS KABI CANADA LTD

Austria

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Austria

Digital Content

Regulatory Info :

Registration Country : Canada

CEFTAZIDIME

Brand Name : CEFTAZIDIME FOR INJECTION, USP

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 1G/VIAL

Packaging : 3.6ML(I.M)/5.6/10.6ML(I.V.)

Approval Date :

Application Number : 886971

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

STERIMAX INC

PharmScience R&D

Not Confirmed

STERIMAX INC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

Brand Name : CEFTAZIDIME FOR INJECTION BP

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 1G/VIAL

Packaging : I.M: 3.9ML/ I.V: 10.9ML

Approval Date :

Application Number : 2437848

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

STERIMAX INC

PharmScience R&D

Not Confirmed

STERIMAX INC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

Brand Name : CEFTAZIDIME FOR INJECTION BP

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 2G/VIAL

Packaging : 11.7ML

Approval Date :

Application Number : 2437856

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

STERIMAX INC

PharmScience R&D

Not Confirmed

STERIMAX INC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

Brand Name : CEFTAZIDIME FOR INJECTION BP

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 6G/VIAL

Packaging : 30ML

Approval Date :

Application Number : 2437864

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!